Inhibition of HDM2 and Activation of p53 by Ribosomal Protein L23

ABSTRACT The importance of coordinating cell growth with proliferation has been recognized for a long time. The molecular basis of this relationship, however, is poorly understood. Here we show that the ribosomal protein L23 interacts with HDM2. The interaction involves the central acidic domain of HDM2 and an N-terminal domain of L23. L23 and L11, another HDM2-interacting ribosomal protein, can simultaneously yet distinctly interact with HDM2 together to form a ternary complex. We show that, when overexpressed, L23 inhibits HDM2-induced p53 polyubiquitination and degradation and causes a p53-dependent cell cycle arrest. On the other hand, knocking down L23 causes nucleolar stress and triggers translocation of B23 from the nucleolus to the nucleoplasm, leading to stabilization and activation of p53. Our data suggest that cells may maintain a steady-state level of L23 during normal growth; alternating the levels of L23 in response to changing growth conditions could impinge on the HDM2-p53 pathway by interrupting the integrity of the nucleolus.

[1]  M. Oren,et al.  mdm 2 expression is induced by wild type p 53 activity , 2004 .

[2]  T. Allio,et al.  Ribosomal Protein L11 Negatively Regulates Oncoprotein MDM2 and Mediates a p53-Dependent Ribosomal-Stress Checkpoint Pathway , 2003, Molecular and Cellular Biology.

[3]  J. Milner,et al.  Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses , 2003, The EMBO journal.

[4]  David Hawke,et al.  Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. , 2003, Molecular cell.

[5]  M. Kubbutat,et al.  Regulation of HDM2 activity by the ribosomal protein L11. , 2003, Cancer cell.

[6]  P. Pandolfi,et al.  Does the ribosome translate cancer? , 2003, Nature Reviews Cancer.

[7]  Xin Lu,et al.  Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.

[8]  Pier Giuseppe Pelicci,et al.  Nucleophosmin regulates the stability and transcriptional activity of p53 , 2002, Nature Cell Biology.

[9]  Goberdhan P Dimri,et al.  A Role for p53 in Maintaining and Establishing the Quiescence Growth Arrest in Human Cells* , 2002, The Journal of Biological Chemistry.

[10]  G. Schwartsmann,et al.  Natural products in anticancer therapy. , 2001, Current opinion in pharmacology.

[11]  Lester F. Lau,et al.  Evidence of p53-Dependent Cross-Talk between Ribosome Biogenesis and the Cell Cycle: Effects of Nucleolar Protein Bop1 on G1/S Transition , 2001, Molecular and Cellular Biology.

[12]  Y. Xiong,et al.  A p53 Amino-Terminal Nuclear Export Signal Inhibited by DNA Damage-Induced Phosphorylation , 2001, Science.

[13]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[14]  H. F. Horn,et al.  Nucleophosmin/B23 Is a Target of CDK2/Cyclin E in Centrosome Duplication , 2000, Cell.

[15]  D. Lane,et al.  An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo , 2000, Oncogene.

[16]  G. Thomas.  An encore for ribosome biogenesis in the control of cell proliferation , 2000, Nature Cell Biology.

[17]  J. D. Weber,et al.  The ARF/p53 pathway. , 2000, Current opinion in genetics & development.

[18]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[19]  M. Olson,et al.  Nucleolar protein B23 has molecular chaperone activities , 2008, Protein science : a publication of the Protein Society.

[20]  D. Meek,et al.  Mechanisms of switching on p53: a role for covalent modification? , 1999, Oncogene.

[21]  J. Warner,et al.  The economics of ribosome biosynthesis in yeast. , 1999, Trends in biochemical sciences.

[22]  H. Naora,et al.  Involvement of ribosomal proteins in regulating cell growth and apoptosis: Translational modulation or recruitment for extraribosomal activity? , 1999, Immunology and cell biology.

[23]  Y. Xiong,et al.  Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. , 1999, Molecular cell.

[24]  I. Conlon,et al.  Size Control in Animal Development , 1999, Cell.

[25]  C. Prives,et al.  The p53 pathway , 1999, The Journal of pathology.

[26]  T. P. Neufeld,et al.  Connections between growth and the cell cycle. , 1998, Current opinion in cell biology.

[27]  A. Giaccia,et al.  The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.

[28]  R. Savkur,et al.  Preferential cleavage in pre-ribosomal RNA byprotein B23 endoribonuclease. , 1998, Nucleic acids research.

[29]  H. Naora,et al.  Altered Cellular Responses by Varying Expression of a Ribosomal Protein Gene: Sequential Coordination of Enhancement and Suppression of Ribosomal Protein S3a Gene Expression Induces Apoptosis , 1998, The Journal of cell biology.

[30]  Yue Xiong,et al.  ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways , 1998, Cell.

[31]  Hirofumi Tanaka,et al.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 , 1997, FEBS letters.

[32]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[33]  R. Tjian,et al.  Repression of p53-mediated transcription by MDM2: a dual mechanism. , 1997, Genes & development.

[34]  Stephen N. Jones,et al.  Regulation of p53 stability by Mdm2 , 1997, Nature.

[35]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[36]  U. Krawinkel,et al.  Constitutive expression of human ribosomal protein L7 arrests the cell cycle in G1 and induces apoptosis in Jurkat T-lymphoma cells. , 1997, Experimental cell research.

[37]  I. Wool.  Extraribosomal functions of ribosomal proteins. , 1996, Trends in biochemical sciences.

[38]  G. Wahl,et al.  A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. , 1996, Genes & development.

[39]  A. Levine,et al.  The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes , 1994, Molecular and cellular biology.

[40]  M. Scheffner,et al.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.

[41]  A. Levine,et al.  The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.

[42]  M. Oren,et al.  mdm2 expression is induced by wild type p53 activity. , 1993, The EMBO journal.

[43]  A. Levine,et al.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.

[44]  M. Olson,et al.  Preribosomal ribonucleoprotein particles are a major component of a nucleolar matrix fraction. , 1986, Biochemistry.

[45]  M. T. Franze-Fernández,et al.  Effect of protein synthesis inhibitors and low concentrations of actinomycin D on ribosomal RNA synthesis , 1979, FEBS letters.

[46]  R. Perry,et al.  Inhibition of RNA synthesis by actinomycin D: Characteristic dose‐response of different RNA species , 1970, Journal of cellular physiology.